BioSpace News Archive

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important enhancements in the commercialization of its QIAstat-Dx syndromic testing solution – which enables laboratories and hospitals worldwide to test patients for multiple pathogens from one sample – with new tests and the launch of a higher-throughput version that includes a new level of walk-away efficiency through the new QIAstat-Dx Smart Drawer.

According to Emergen Research, the global animal ultrasound market size was USD 286.2 Million in 2020 and is expected to reach USD 532.5 million in 2028 and register a revenue CAGR of 8.2% during the forecast period, 2021-2028.

According to Emergen Research, the global healthcare Internet of Things (IoT) market size was USD 1.15 Billion in 2020 and is expected to reach USD 5.52 Billion in 2028 and register a revenue CAGR of 21.6% during the forecast period, 2021-2028.

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines, announced today the appointment of Todd P. Branning as Chief Financial Officer (CFO).

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it has entered into a definitive agreement to acquire assets related to Theravant Corporation’s TheraClear System.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, reported, as required by Nasdaq Stock Market Rules, an equity inducement award to John D. Gerace, the Company’s new Chief Commercial Officer.

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference.

Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, announced a multi-year partnership with Illumina, Inc., to co-develop in vitro diagnostic tests for oncology testing.

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today confirmed the company is positioned for growth in the mid- and long-term with the potential to deliver incremental revenue growth and additional upside potential through FY2030.

On January 7, 2022, the world’s first ever successful pig to human heart transplantation took place, a groundbreaking milestone for the field of transplantation.